Terminalia arjuna in coronary artery disease: ethnopharmacology, pre-clinical, clinical & safety evaluation.
about
Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: A review.Terminalia arjuna prevents Interleukin-18-induced atherosclerosis via modulation of NF-κB/PPAR-γ-mediated pathway in Apo E-/- mice.Short-Term Adjuvant Therapy with Terminalia arjuna Attenuates Ongoing Inflammation and Immune Imbalance in Patients with Stable Coronary Artery Disease: In Vitro and In Vivo Evidence.Ethanolic Fraction of Terminalia tomentosa Attenuates Biochemical and Physiological Derangements in Diet Induced Obese Rat Model by Regulating Key Lipid Metabolizing Enzymes and AdipokinesIn vitro modulatory effects of Terminalia arjuna, arjunic acid, arjunetin and arjungenin on CYP3A4, CYP2D6 and CYP2C9 enzyme activity in human liver microsomes.Toxicological and hematological effect of Terminalia arjuna bark extract on a freshwater catfish, Heteropneustes fossilis.
P2860
Terminalia arjuna in coronary artery disease: ethnopharmacology, pre-clinical, clinical & safety evaluation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Terminalia arjuna in coronary ...... clinical & safety evaluation.
@ast
Terminalia arjuna in coronary ...... clinical & safety evaluation.
@en
type
label
Terminalia arjuna in coronary ...... clinical & safety evaluation.
@ast
Terminalia arjuna in coronary ...... clinical & safety evaluation.
@en
prefLabel
Terminalia arjuna in coronary ...... clinical & safety evaluation.
@ast
Terminalia arjuna in coronary ...... clinical & safety evaluation.
@en
P1476
Terminalia arjuna in coronary ...... , clinical & safety evaluation
@en
P2093
Divya Kapoor
Veena Dhawan
P304
P356
10.1016/J.JEP.2014.06.056
P577
2014-07-08T00:00:00Z